BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19670955)

  • 1. Cost evaluation of a coordinated care management intervention for dementia.
    Duru OK; Ettner SL; Vassar SD; Chodosh J; Vickrey BG
    Am J Manag Care; 2009 Aug; 15(8):521-8. PubMed ID: 19670955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residential Setting and the Cumulative Financial Burden of Dementia in the 7 Years Before Death.
    Kelley AS; McGarry K; Bollens-Lund E; Rahman OK; Husain M; Ferreira KB; Skinner JS
    J Am Geriatr Soc; 2020 Jun; 68(6):1319-1324. PubMed ID: 32187655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of a family meetings intervention to prevent depression and anxiety in family caregivers of patients with dementia: a randomized trial.
    Joling KJ; Bosmans JE; van Marwijk HW; van der Horst HE; Scheltens P; MacNeil Vroomen JL; van Hout HP
    Trials; 2013 Sep; 14():305. PubMed ID: 24053631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Care Utilization and Cost Outcomes of a Comprehensive Dementia Care Program for Medicare Beneficiaries.
    Jennings LA; Laffan AM; Schlissel AC; Colligan E; Tan Z; Wenger NS; Reuben DB
    JAMA Intern Med; 2019 Feb; 179(2):161-166. PubMed ID: 30575846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of care for dementia patients in community setting: an analysis for mild and moderate disease stage.
    Schwarzkopf L; Menn P; Kunz S; Holle R; Lauterberg J; Marx P; Mehlig H; Wunder S; Leidl R; Donath C; Graessel E
    Value Health; 2011; 14(6):827-35. PubMed ID: 21914502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of the Namaste care family program for nursing home residents with advanced dementia in comparison with usual care: a cluster-randomized controlled trial.
    El Alili M; Smaling HJA; Joling KJ; Achterberg WP; Francke AL; Bosmans JE; van der Steen JT
    BMC Health Serv Res; 2020 Sep; 20(1):831. PubMed ID: 32887591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The economic and social burden of dementia diseases in Germany-A meta-analysis].
    Michalowsky B; Kaczynski A; Hoffmann W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Aug; 62(8):981-992. PubMed ID: 31297549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare utilization and costs in primary care patients with dementia: baseline results of the DelpHi-trial.
    Michalowsky B; Flessa S; Eichler T; Hertel J; Dreier A; Zwingmann I; Wucherer D; Rau H; Thyrian JR; Hoffmann W
    Eur J Health Econ; 2018 Jan; 19(1):87-102. PubMed ID: 28160100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of dementia in Hungary.
    Érsek K; Kovács T; Wimo A; Kárpati K; Brodszky V; Péntek M; Jönsson L; Gustavsson A; McDaid D; Kenigsberg PA; Valtonen H; Gulácsi L
    J Nutr Health Aging; 2010 Oct; 14(8):633-9. PubMed ID: 20922339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. REMCARE: Pragmatic Multi-Centre Randomised Trial of Reminiscence Groups for People with Dementia and their Family Carers: Effectiveness and Economic Analysis.
    Woods RT; Orrell M; Bruce E; Edwards RT; Hoare Z; Hounsome B; Keady J; Moniz-Cook E; Orgeta V; Rees J; Russell I
    PLoS One; 2016; 11(4):e0152843. PubMed ID: 27093052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informal costs of dementia care: estimates from the National Longitudinal Caregiver Study.
    Moore MJ; Zhu CW; Clipp EC
    J Gerontol B Psychol Sci Soc Sci; 2001 Jul; 56(4):S219-28. PubMed ID: 11445614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification tree model of the personal economic burden of dementia care by related factors of both people with dementia and caregivers in Japan: a cross-sectional online survey.
    Nakabe T; Sasaki N; Uematsu H; Kunisawa S; Wimo A; Imanaka Y
    BMJ Open; 2019 Jul; 9(7):e026733. PubMed ID: 31289069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who Benefits Most from Collaborative Dementia Care from a Patient and Payer Perspective? A Subgroup Cost-Effectiveness Analysis.
    Rädke A; Michalowsky B; Thyrian JR; Eichler T; Xie F; Hoffmann W
    J Alzheimers Dis; 2020; 74(2):449-462. PubMed ID: 32039839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the REACH II and REACH VA Dementia Caregiver Interventions on Healthcare Costs.
    Nichols LO; Martindale-Adams J; Zhu CW; Kaplan EK; Zuber JK; Waters TM
    J Am Geriatr Soc; 2017 May; 65(5):931-936. PubMed ID: 28295134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic Analysis of Formal Care, Informal Care, and Productivity Losses in Primary Care Patients who Screened Positive for Dementia in Germany.
    Michalowsky B; Thyrian JR; Eichler T; Hertel J; Wucherer D; Flessa S; Hoffmann W
    J Alzheimers Dis; 2016; 50(1):47-59. PubMed ID: 26639964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monetary costs of dementia in the United States.
    Hurd MD; Martorell P; Delavande A; Mullen KJ; Langa KM
    N Engl J Med; 2013 Apr; 368(14):1326-34. PubMed ID: 23550670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The costs of dementia from the societal perspective: is care provided in the community really cheaper than nursing home care?
    König HH; Leicht H; Brettschneider C; Bachmann C; Bickel H; Fuchs A; Jessen F; Köhler M; Luppa M; Mösch E; Pentzek M; Werle J; Weyerer S; Wiese B; Scherer M; Maier W; Riedel-Heller SG;
    J Am Med Dir Assoc; 2014 Feb; 15(2):117-26. PubMed ID: 24321877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TECH@HOME study, a technological intervention to reduce caregiver burden for informal caregivers of people with dementia: study protocol for a randomized controlled trial.
    Malmgren Fänge A; Schmidt SM; Nilsson MH; Carlsson G; Liwander A; Dahlgren Bergström C; Olivetti P; Johansson P; Chiatti C;
    Trials; 2017 Feb; 18(1):63. PubMed ID: 28183323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with costs of care in community-dwelling persons with dementia from a third party payer and societal perspective: a cross-sectional study.
    Vandepitte S; Van Wilder L; Putman K; Van Den Noortgate N; Verhaeghe S; Trybou J; Annemans L
    BMC Geriatr; 2020 Jan; 20(1):18. PubMed ID: 31948386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and cost-effectiveness of an in-home respite care program in supporting informal caregivers of people with dementia: design of a comparative study.
    Vandepitte S; Van Den Noortgate N; Putman K; Verhaeghe S; Annemans L
    BMC Geriatr; 2016 Dec; 16(1):207. PubMed ID: 27912740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.